Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Johnson and Johnson
US Department of Justice
Accenture
Colorcon
Federal Trade Commission
Chinese Patent Office
Harvard Business School
Chubb

Generated: November 14, 2018

DrugPatentWatch Database Preview

Tentative Approvals for: fosaprepitant dimeglumine

« Back to Dashboard

fosaprepitant dimeglumine Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Sandoz Inc fosaprepitant dimeglumine 203939 150MG INJECTABLE;INJECTION
Applicant Generic Name NDA Strength Dosage Form

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Covington
Daiichi Sankyo
Federal Trade Commission
US Department of Justice
Colorcon
McKinsey
Harvard Business School
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.